MMDMA
 | |
| Clinical data | |
|---|---|
| Other names | 5-Methoxy-MDMA; 5-MeO-MDMA; 5-Methoxy-3,4-methylenedioxy-N-methylamphetamine; 3-Methoxy-4,5-methylenedioxy-N-methylamphetamine;[1] |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-Methoxy-3,4-methylenedioxymethamphetamine (MMDMA; 5-MeO-MDMA) is a designer drug of the substituted methylenedioxyphenethylamine (MDxx) class.[2][1][3] Little is known about its effects and it has not been formally studied in animals.
See also
[edit]References
[edit]- 1 2 Bailey K, By A, Legault D, Verner D (1976). "Identification of the N-Methylated Analogs of the Hallucinogenic Amphetamines and Some Isomers". Journal of the Association of Official Analytical Chemists. 58 (1): 62–69. Archived from the original on 2022-03-30. Retrieved 2024-05-27.
- ↑ Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
- ↑ Clark CR, Deruiter J, Noggle FT (1996). "Analysis of 1-(3-methoxy-4,5-methylenedioxyphenyl)-2-propanamine (MMDA) derivatives synthesized from nutmeg oil and 3-methoxy-4,5-methylenedioxybenzaldehyde". Journal of Chromatographic Science. 34 (1): 34–42. doi:10.1093/chromsci/34.1.34.